{"data":{"id":"us-me/32-m.r.s.-13845","jurisdiction":"us-me","citation":"32 M.R.S. §13845","heading":"Practice protocols","body":"A pharmacist may engage in collaborative drug therapy management in compliance with a treatment protocol established by the practitioner with whom the pharmacist has a collaborative practice agreement.  A copy of the treatment protocol must be submitted to the board.  At a minimum, the treatment protocol must include a statement by the practitioner that describes the activities in which the pharmacist is authorized to engage and a provision that allows the practitioner, when appropriate, to override a collaborative practice decision made by the pharmacist.","path":["TITLE 32: PROFESSIONS AND OCCUPATIONS","CHAPTER 117: MAINE PHARMACY ACT","SUBCHAPTER 14: COLLABORATIVE DRUG THERAPY MANAGEMENT"],"source_url":"https://legislature.maine.gov/statutes/32/title32sec13845.html","current_through":"October 1, 2025","vintage":"","retrieved_at":"2026-09-04T15:12:37Z","sha256":"ecd8b6b8fdef7aadc0dc5933b9b048ab2cd52de1adc9ade5aabbc21016690066","source_id":"us-me","stale":false,"prev":"us-me/32-m.r.s.-13844","next":"us-me/32-m.r.s.-13846"},"notice":"GroundRules: Original legal text. Not legal advice."}